NCMP-08. CLINICAL FEATURES OF CAR T-CELL THERAPY NEUROTOXICITY AS POTENTIAL SURROGATE MARKERS FOR PROGRESSION AND OUTCOME

CAR T-cell therapy related neurotoxicity (NT) is common and can lead to fatalities. Early recognition may improve its management and treatment. METHODS: Twenty-six patients with relapsed/refractory diffuse large B cell lymphoma who received commercial CAR T-cell therapy (25 axicabtagene ciloleucel [...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Yuen, Carlen, Artz, Andrew, Kelly, Thomas, Wu, Shasha, Reder, Anthony, Rezania, Kourosh, Soliven, Betty, Xie, Tao, Mastrianni, James, Park, Deric, Kosuri, Satyajit, Riedell, Peter, Klejch, Wesley, Ali, Saad, Bishop, Michael
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Neurological Complications of Cancer and Cancer Therapy
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847571/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.754
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires